Back to Search
Start Over
API prices to remain weak for India in FY25, says Ind-Ra report
- Source :
- PharmaBiz. September 24, 2024
- Publication Year :
- 2024
-
Abstract
- Byline: Our Bureau Active pharmaceutical ingredient (API) prices and volume growth are expected to remain weak for India in FY25, driven by imports and competition in exports, both from China, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.809770093